Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

ClinicalTrials.gov ID: NCT06220604

Public ClinicalTrials.gov record NCT06220604. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Study identification

NCT ID
NCT06220604
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
731 participants

Conditions and interventions

Interventions

  • JNJ-77242113 Drug
  • JNJ-77242113 Matching Placebo Drug
  • Deucravacitinib Drug
  • Deucravacitinib Matching Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 8, 2024
Primary completion
Nov 14, 2024
Completion
Sep 19, 2027
Last update posted
Jul 6, 2026

2024 – 2027

United States locations

U.S. sites
37
U.S. states
18
U.S. cities
35
Facility City State ZIP Site status
Alliance Dermatology and MOHS Center P C Phoenix Arizona 85032
California Dermatology & Clinical Research Institute Encinitas California 92024
T Joseph Raoof Md Inc Encino California 91436
UCSF Fresno Fresno California 93701
University of California Los Angeles - Division of Dermatology Los Angeles California 90024
Wallace Medical Group, Inc Los Angeles California 90056
Dermatologist Medical Group of North County, Inc. Oceanside California 92056
Miami Dermatology And Laser Institute Miami Florida 33133
Bioclinical Research Alliance Inc. Miami Florida 33155
Forcare Clinical Research Inc Tampa Florida 33613
Southeast Dermatology Specialists Douglasville Georgia 30135
Arlington Dermatology Rolling Meadows Illinois 60008
Skin Sciences, PLLC Louisville Kentucky 40217
Qualmedica Research Owensboro Kentucky 42301
DermAssociates, PC Rockville Maryland 20850
Metro Boston Clinical Partners Brighton Massachusetts 02135
ActivMed Practices and Research Methuen Massachusetts 01844
University of Michigan Ann Arbor Michigan 48109
Great Lakes Research Group Bay City Michigan 48706
The Derm Institute of West Michigan Caledonia Michigan 49316
Hamzavi Dermatology Canton Michigan 48187
Somerset Skin Centre Troy Michigan 48084
Cleaver Dermatology Kirksville Missouri 63501
Bexley dermatology research Bexley Ohio 43209
Essential Medical Research Tulsa Oklahoma 74137
Oregon Dermatology & Research Center Portland Oregon 97210-2996
Paddington Testing Co, Inc. Philadelphia Pennsylvania 19103
Clinical Research Center of the Carolinas LLC Charleston South Carolina 29407
Palmetto Clinical Trial Services, LLC Greenville South Carolina 29615
Arlington Research Center, Inc. Arlington Texas 76011
UT Southwestern Medical Center Dallas Texas 75390
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229
Center for Clinical Studies Webster Texas 77598
Cope Family Medicine - Ogden Clinic Bountiful Utah 84010
Springville Dermatology CCT Research Springville Utah 84663
Kalo Clinical Research West Valley City Utah 84120
Virginia Dermatology Skin Cancer Center Pllc Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06220604, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06220604 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →